Oncology
In this section you will find Therapeutics Diseases & Conditions Oncology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Triple Analysis: Leukemia, Angiogenesis and Cancer Vaccines
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More -
Triple Analysis: Lung Cancer, Angiogenesis and Antibodies
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Melanoma, Angiogenesis and Antibodies
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Apoptosis, Angiogenesis and Peptides
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Angiogenesis and by the compound strategy of Peptides. Learn More -
Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More -
Triple Analysis: Breast Cancer, Angiogenesis and Antibodies
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccines
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More -
Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Apoptosis, Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Angiogenesis and Cancer Vaccines
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More -
Triple Analysis: Colorectal Cancer, Angiogenesis and Antibodies
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Lymphoma, Melanoma and Angiogenesis
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More -
Triple Analysis: Leukemia, Lung Cancer and Angiogenesis
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the mechanism/target/effect of Angiogenesis. Learn More -
Triple Analysis: Leukemia, Melanoma and Angiogenesis
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More -
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors and by the compound strategy of Peptides. Learn More -
Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines
€3,450.00Published by BioSeeker Group on Jan 30th, 2012This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More